Amyloid beta peptides (such as Aβ42 and Aβ40), Tau protein (such as P-tau 181 and P-tau 217), and Apolipoprotein E4 (APOE4) have been commonly used for AD biomarker detection [8]. This evidence concerns the gene MAPT and Alzheimer disease.